Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
03/1991
03/22/1991CA2042034A1 Treatment of conditions and disease
03/20/1991EP0417209A1 Compositions and methods for administering therapeutically active compounds
03/19/1991US5001160 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders
03/19/1991US5000937 Transparent cosmetic composition that reflects infrared radiation and its use for protecting the human epidermis against infrared radiation
03/13/1991EP0416837A1 Photoprotection compositions having reduced dermal irritation
03/13/1991EP0416678A1 Topical compositions containing Defibrotide
03/13/1991EP0416011A1 Chemotherapeutic composition for aids
03/12/1991US4999341 Appetite moderating and anti-gastritis composition
03/12/1991US4999291 Production of human pluripotent granulocyte colony-stimulating factor
03/12/1991CA1281290C Nonfoaming cleansing mousse with skin conditioning benefits
03/12/1991CA1281287C Protection of equines against streptococcus equi
03/09/1991CA2024884A1 Photoprotection compositions having reduced dermal irritation
03/08/1991CA2021874A1 Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility
03/07/1991WO1991002721A1 5-(1-aminocyclohexyl)-2(1h)-pyridinone and related compounds
03/07/1991DE3929333A1 Egalisierende oxidationshaarfaerbemittel Equalizing oxidation hair
03/07/1991DE3929173A1 Verfahren zur haarfaerbung mit direktfarbstoffen Method for haarfaerbung with direct dyes
03/06/1991EP0414700A1 Contrast agents for magnetic resonance imaging.
03/05/1991WO1991003230A1 Oxidative hair dye with levelling action
03/05/1991US4997850 Alcohol or ester
03/05/1991US4997640 Oral compositions
03/05/1991CA2066399A1 Oxidative hair dye with levelling action
03/03/1991WO1991003231A1 Hair-dyeing process using direct dyes
03/03/1991CA2066446A1 Hair-dyeing process using direct dyes
02/1991
02/19/1991US4994618 Bevantolol preparation
02/19/1991US4994567 Purification by recovering from solution by roller drying
02/19/1991CA1280369C Pharmaceutical with anti-tumor effect
02/13/1991EP0412947A1 Cosmetic use of 3-indolepyruvic acid
02/13/1991CN1049101A Improved intravaginal treatment of vaginal infections with buffered metranidazole compositions
02/13/1991CN1011572B Process of the preparation of basic formulations of quinolonecarboxylic acids
02/07/1991WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease
02/07/1991WO1991001130A1 Oral osmotic device with hydrogel driving member
02/06/1991EP0411031A1 THE HUMAN C3b/C4b RECEPTOR (CR1)
02/06/1991EP0231209B1 Virus vaccine
02/05/1991US4990621 Insecticides, miticides and nematocides; 3-(3-fluoro-4-phenoxyphenyl, 3-(5-fluoro-3-phenoxypyrid-2-yl) or 3-(3-methyl-4-phenyl prop-1-ene
02/05/1991CA1279868C 3-(substituted)propenylaminothiazolylcephalosporanic acids and esters thereof
01/1991
01/30/1991EP0410659A2 Method and composition to impart improved conditioning properties to the hair
01/30/1991EP0409862A1 Topical preparations.
01/29/1991WO1991001738A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility
01/29/1991CA2064036A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility
01/26/1991WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates
01/24/1991CA2019816A1 Method and composition to impart improved conditioning properties to the hair
01/23/1991EP0409302A2 Cosmetics
01/23/1991CN1011287B Oral hygiene composition
01/22/1991US4986982 Pyroglutamic ester which penetrates skin and is hydrolyzed in situ to moisturizing pyroglutamic acid
01/22/1991CA2060651A1 Anthelmintic non-living vaccine
01/16/1991EP0408509A2 Substituted benzonitriles
01/15/1991US4985442 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
01/15/1991US4985436 Composition of matter for inhibiting leukemias and sarcomas
01/15/1991US4985435 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
01/15/1991US4985238 Low residue antiperspirant sticks
01/15/1991CA2021049A1 Substituted benzonitriles
01/15/1991CA1279011C Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
01/10/1991WO1991000295A1 Novel antibodies reactive with human carcinomas
01/10/1991WO1991000090A1 Oxygenation of blood substitutes
01/10/1991WO1990012560A3 Preparation for care of nails, skin and hair
01/09/1991EP0406512A1 Polysaccharide fraction with anti-HIV activity
01/09/1991EP0315638B1 Use of sulfonamide derivatives for the preparation of an antiviral medicament
01/09/1991CN1048422A Cationic surface active fiber conditioning compositions comprising compounds including long chain hydrocarbyl groups
01/09/1991CN1048390A N-acyl derivatives of ll-e 33288 antitumor antibiotics
01/04/1991WO1991000853A1 Use of polyamines as ionic-channel regulating agents
01/04/1991CA2062810A1 Use of polyamines as ionic-channel regulating agents
01/04/1991CA2018942A1 Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
01/02/1991EP0405233A1 Diphenylurea derivatives
01/02/1991CN1048214A Antiarrhytmic agents ii
01/01/1991US4981682 Mercaptocarboxylci acid, tertiary amine
12/1990
12/29/1990CA2019992A1 Antibiotic ll-e19085
12/27/1990EP0404376A2 Buffered metronidazole compositions for intravaginal treatment of vaginal infections
12/27/1990EP0404115A1 Bis(benzylpyrrolidine)Derivatives as dopamine agonists
12/21/1990CA2019464A1 Bis (benzylpyrrolidine) derivatives as dopamine agonists
12/21/1990CA2019358A1 Cationic surface active fiber conditioning compositions comprising compounds including long chain hydrocarbyl groups
12/19/1990EP0403304A2 Shampoo composition
12/19/1990EP0403303A2 Hair treatment composition
12/19/1990CN1047863A 3-keto hmg-co a reductase inhibitors
12/18/1990US4978663 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
12/18/1990CA1277937C Complexable heterogeneous oligosaccharides and alpha-hydosanes having therapeuticaltivity, process for thier preparation and related pharmaceutical compositions
12/18/1990CA1277915C Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2'3' -dideoxycytidine
12/18/1990CA1277914C Use of dopamine agonists
12/15/1990CA2018848A1 Diphenylurea derivatives
12/13/1990WO1990014832A1 Improved intravaginal treatment of vaginal infections with buffered metronidazole compositions
12/13/1990WO1990014818A1 Oxidation hair colorant
12/11/1990US4977148 Thermogenic stimulants for obesity or diabetes
12/11/1990US4976956 Water soluble and oil soluble quaternary ammonium compounds and amidoamine
12/11/1990US4976742 META-aminophenols useful as oxidation hair dye couplers
12/11/1990CA1277659C Tricyclic pyridine derivatives
12/05/1990EP0400858A2 Cleansing commpositions
12/05/1990EP0400546A1 Stable anhydrous compositions for topical delivery of active materials
12/05/1990EP0400545A1 Derivative of tissue plasminogen activator
12/05/1990EP0400330A1 Oxidation hair dyes
12/05/1990CN1047531A Hog cholera virus vaccine and diagnostic
12/04/1990US4975458 2-alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
12/03/1990WO1990014829A1 Lysolecithin derivatives for treating autoimmune diseases
11/1990
11/28/1990EP0399746A1 Use of chlorites as oxidants in hair coloring
11/28/1990EP0399094A2 Improved process for the preparation of ceftriaxone
11/27/1990CA2017519A1 Cleansing compositions
11/20/1990US4971982 Benzopyran derivatives
11/20/1990US4971801 Natural membranes vesicles and ribosomes
11/20/1990US4971596 Process for dyeing hair with hydroxyquinone dyes and metal salts
11/13/1990US4970298 Wound healing agents, crosslinked collagen sponge
11/13/1990US4970230 Drugs containing a psoralene derivative
11/07/1990EP0396081A2 The use of phosphatidyl-carnitine for the preparation of pharmaceutical compositions having an activity in the therapy of human pathologies associated with neuronal damage